Pathological response and predictive role of tumour-infiltrating lymphocytes in HER2-positive early breast cancer treated with neoadjuvant pyrotinib plus trastuzumab and chemotherapy (Panphila): a multicentre phase 2 trial

医学 曲妥珠单抗 内科学 乳腺癌 肿瘤科 卡铂 人口 多西紫杉醇 胃肠病学 化疗 癌症 顺铂 环境卫生
作者
Zhenzhen Liu,Chengzheng Wang,Xiuchun Chen,Jiujun Zhu,Xianfu Sun,Qingxin Xia,Zhenduo Lu,Jianghua Qiao,Yong Zhou,Haixue Wang,Yi Wang,Min Yan
出处
期刊:European Journal of Cancer [Elsevier]
卷期号:165: 157-168 被引量:27
标识
DOI:10.1016/j.ejca.2022.01.022
摘要

Panphila evaluated pyrotinib plus trastuzumab, docetaxel and carboplatin as neoadjuvant therapy for early breast cancer (BC), and investigated the predictive role of immune cell subpopulations.In this multicentre phase 2 study, patients with human epidermal growth factor receptor 2-positive, stage T2-3N0-3M0 BC received pyrotinib 400 mg once daily plus docetaxel (75 mg/m2, day 1), carboplatin (6 mg/mL/min, day 1) and trastuzumab (8 mg/kg loading dose and 6 mg/kg maintenance dose, day 1) for 6 cycles of 21 days each. Simon's 2-stage design was adopted. The primary end-point was pathological complete response (pCR, ypT0/is ypN0) rate. Tumour-infiltrating lymphocytes (TILs) were assessed by haematoxylin and eosin staining and multiplex immunohistochemistry.In the modified intention-to-treat population (n = 69), 38 patients (55.1%) achieved pCR. In the safety population (n = 74), the most common grade ≥3 adverse events were diarrhoea (43.2%), anaemia (37.8%), vomiting (16.2%) and platelet count decrease (10.8%). No treatment-related deaths occurred. Analysis of single immune subpopulations revealed a significant association of pCR with higher baseline infiltration by stromal (s)-CD20+, s-CD8+ and s-CD4+ TILs. Unsupervised hierarchical clustering of stromal immune markers identified a group of patients characterised by high s-CD20+, s-CD8+, s-CD4+ and s-FOXP3+ immune cells infiltration, which was independently associated with pCR.Neoadjuvant pyrotinib plus trastuzumab-based chemotherapy exhibits promising efficacy and manageable toxicity in patients with human epidermal growth factor receptor 2-positive early BC, and thus phase 3 trials are warranted. Our findings also contribute to understanding the potential role of the immune microenvironment in response to neoadjuvant pyrotinib-based therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hoozhwen发布了新的文献求助10
刚刚
Jasper应助小景007采纳,获得10
1秒前
1秒前
二三发布了新的文献求助10
3秒前
3秒前
ZAO发布了新的文献求助10
3秒前
4秒前
我爱化学完成签到,获得积分10
4秒前
满意沛槐完成签到 ,获得积分10
4秒前
4秒前
5秒前
今天搞学问没完成签到,获得积分10
5秒前
6秒前
KoitoYuu发布了新的文献求助30
6秒前
6秒前
小马完成签到,获得积分10
7秒前
hh完成签到,获得积分10
9秒前
热情语堂发布了新的文献求助10
9秒前
李由发布了新的文献求助10
10秒前
在水一方应助helium采纳,获得10
10秒前
amber发布了新的文献求助10
10秒前
各位大牛帮帮忙完成签到 ,获得积分10
10秒前
flippedaaa发布了新的文献求助10
10秒前
11秒前
潘潘婷发布了新的文献求助10
13秒前
13秒前
想要发文章完成签到,获得积分10
15秒前
16秒前
16秒前
HaHa发布了新的文献求助10
16秒前
吴彦祖发布了新的文献求助10
16秒前
16秒前
16秒前
充电宝应助MAY采纳,获得10
17秒前
ccc完成签到,获得积分10
19秒前
活泼水桃完成签到,获得积分10
19秒前
冷公子发布了新的文献求助10
21秒前
21秒前
光锥完成签到,获得积分10
22秒前
22秒前
高分求助中
The late Devonian Standard Conodont Zonation 2000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Very-high-order BVD Schemes Using β-variable THINC Method 830
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3247247
求助须知:如何正确求助?哪些是违规求助? 2890639
关于积分的说明 8264046
捐赠科研通 2559077
什么是DOI,文献DOI怎么找? 1387740
科研通“疑难数据库(出版商)”最低求助积分说明 650640
邀请新用户注册赠送积分活动 627321